ニュース

Trump's FDA drops Covid vaccine bombshell as Pfizer and Moderna admit heart damage risk
The FDA is forcing Pfizer and Moderna to expand warning labels about the risks of two forms of heart damage, myocarditis and ...
FDA advisers debate COVID vaccine recipe amid questions about fall shots
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...
FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines
The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning ...
MPR7 時間
Moderna Withdraws BLA for Flu/COVID-19 Combo Vaccine Candidate
Moderna has withdrawn the Biologics License Application (BLA) for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after ...
Healio1 時間
FDA tells vaccine makers to expand warning labels on COVID-19 shots
The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...
WKU Public Radio36 分
Vaccine advisers to the FDA recommended changes to COVID vaccines
Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...
FDA requires COVID-19 vaccine makers to warn about risk of heart inflammation
FDA now requires Pfizer and Moderna COVID-19 vaccines to carry expanded warning labels about risks of myocarditis and pericarditis ...
Moderna, Inc. (MRNA) Withdraws Application for COVID-flu Combination Vaccine
Moderna, Inc. (NASDAQ:MRNA) made a name for itself by quickly developing an effective coronavirus vaccine when the world needed it the most. However, the stock has largely struggled since the pandemic ...
米モデルナ、インフル・コロナ混合ワクチンの承認申請取り下げ
[２１日ロイター] - 米バイオ医薬品会社モデルナ(MRNA.O), opens new ...
日経メディカル6 時間
新型コロナ以外で初のmRNAワクチン「エムレスビア」が承認取得
モデルナ・ジャパンは2025年5月19日、RSウイルス（RSV）感染症に対するmRNAワクチン「エムレスビア筋注シリンジ」の日本における製造販売承認を取得したと発表した。エムレスビアはアレックスビー、アブリスボに続いて3剤目となる高齢者に使用可能なR ...